Indirect recognition of donor HLA-DR peptides in organ allograft rejection

Zhuoru Liu, Adriana I. Colovai, Sorina Tugulea, Elaine F. Reed, Peter E. Fisher, Donna Mancini, Eric A. Rose, Raffaello Cortesini, Robert E. Michler, Nicole Suciu-Foca

Research output: Contribution to journalArticle

213 Citations (Scopus)

Abstract

To determine whether indirect allorecognition is involved in heart allograft rejection T cells obtained from peripheral blood and graft biopsy tissues were expanded in the presence of IL-2 and tested in limiting dilution analysis (LDA) for reactivity to synthetic peptides corresponding to the hypervariable regions of the mismatched HLA-DR antigen(s) of the donor. Serial studies of 32 patients showed that T cell reactivity to donor allopeptides was strongly associated with episodes of acute rejection. The frequency of allopeptide reactive T cells was 10-50-fold higher in the graft than in the periphery indicating that T cells activated via the indirect allorecognition pathway participate actively in acute allograft rejection. In recipients carrying a graft differing by two HLA-DR alleles the response appeared to target only one of the mismatched antigens of the donor. Indirect allorecognition was restricted by a single HLA-DR antigen of the host and directed against one immunodominant peptide of donor HLA-DR protein. However, intermolecular spreading was demonstrated in patients with multiple rejection episodes by showing that they develop allopeptide reactivity against the second HLA-DR antigen. These data imply that early treatment to suppress T cell responses through the indirect pathway of allorecognition, such as tolerance induction to the dominant donor determinant, may be required to prevent amplification and perpetuation of the rejection process.

Original languageEnglish (US)
Pages (from-to)1150-1157
Number of pages8
JournalJournal of Clinical Investigation
Volume98
Issue number5
StatePublished - Sep 1 1996
Externally publishedYes

Fingerprint

HLA-DR Antigens
Allografts
T-Lymphocytes
Peptides
Tissue Donors
Transplants
Interleukin-2
Alleles
Biopsy
Antigens
Proteins

Keywords

  • acute rejection
  • allopeptide
  • alloreactivity
  • MHC- restriction
  • T cell determinants

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Liu, Z., Colovai, A. I., Tugulea, S., Reed, E. F., Fisher, P. E., Mancini, D., ... Suciu-Foca, N. (1996). Indirect recognition of donor HLA-DR peptides in organ allograft rejection. Journal of Clinical Investigation, 98(5), 1150-1157.

Indirect recognition of donor HLA-DR peptides in organ allograft rejection. / Liu, Zhuoru; Colovai, Adriana I.; Tugulea, Sorina; Reed, Elaine F.; Fisher, Peter E.; Mancini, Donna; Rose, Eric A.; Cortesini, Raffaello; Michler, Robert E.; Suciu-Foca, Nicole.

In: Journal of Clinical Investigation, Vol. 98, No. 5, 01.09.1996, p. 1150-1157.

Research output: Contribution to journalArticle

Liu, Z, Colovai, AI, Tugulea, S, Reed, EF, Fisher, PE, Mancini, D, Rose, EA, Cortesini, R, Michler, RE & Suciu-Foca, N 1996, 'Indirect recognition of donor HLA-DR peptides in organ allograft rejection', Journal of Clinical Investigation, vol. 98, no. 5, pp. 1150-1157.
Liu Z, Colovai AI, Tugulea S, Reed EF, Fisher PE, Mancini D et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. Journal of Clinical Investigation. 1996 Sep 1;98(5):1150-1157.
Liu, Zhuoru ; Colovai, Adriana I. ; Tugulea, Sorina ; Reed, Elaine F. ; Fisher, Peter E. ; Mancini, Donna ; Rose, Eric A. ; Cortesini, Raffaello ; Michler, Robert E. ; Suciu-Foca, Nicole. / Indirect recognition of donor HLA-DR peptides in organ allograft rejection. In: Journal of Clinical Investigation. 1996 ; Vol. 98, No. 5. pp. 1150-1157.
@article{702664f688f5415a97c8f26ffdebc5cd,
title = "Indirect recognition of donor HLA-DR peptides in organ allograft rejection",
abstract = "To determine whether indirect allorecognition is involved in heart allograft rejection T cells obtained from peripheral blood and graft biopsy tissues were expanded in the presence of IL-2 and tested in limiting dilution analysis (LDA) for reactivity to synthetic peptides corresponding to the hypervariable regions of the mismatched HLA-DR antigen(s) of the donor. Serial studies of 32 patients showed that T cell reactivity to donor allopeptides was strongly associated with episodes of acute rejection. The frequency of allopeptide reactive T cells was 10-50-fold higher in the graft than in the periphery indicating that T cells activated via the indirect allorecognition pathway participate actively in acute allograft rejection. In recipients carrying a graft differing by two HLA-DR alleles the response appeared to target only one of the mismatched antigens of the donor. Indirect allorecognition was restricted by a single HLA-DR antigen of the host and directed against one immunodominant peptide of donor HLA-DR protein. However, intermolecular spreading was demonstrated in patients with multiple rejection episodes by showing that they develop allopeptide reactivity against the second HLA-DR antigen. These data imply that early treatment to suppress T cell responses through the indirect pathway of allorecognition, such as tolerance induction to the dominant donor determinant, may be required to prevent amplification and perpetuation of the rejection process.",
keywords = "acute rejection, allopeptide, alloreactivity, MHC- restriction, T cell determinants",
author = "Zhuoru Liu and Colovai, {Adriana I.} and Sorina Tugulea and Reed, {Elaine F.} and Fisher, {Peter E.} and Donna Mancini and Rose, {Eric A.} and Raffaello Cortesini and Michler, {Robert E.} and Nicole Suciu-Foca",
year = "1996",
month = "9",
day = "1",
language = "English (US)",
volume = "98",
pages = "1150--1157",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - Indirect recognition of donor HLA-DR peptides in organ allograft rejection

AU - Liu, Zhuoru

AU - Colovai, Adriana I.

AU - Tugulea, Sorina

AU - Reed, Elaine F.

AU - Fisher, Peter E.

AU - Mancini, Donna

AU - Rose, Eric A.

AU - Cortesini, Raffaello

AU - Michler, Robert E.

AU - Suciu-Foca, Nicole

PY - 1996/9/1

Y1 - 1996/9/1

N2 - To determine whether indirect allorecognition is involved in heart allograft rejection T cells obtained from peripheral blood and graft biopsy tissues were expanded in the presence of IL-2 and tested in limiting dilution analysis (LDA) for reactivity to synthetic peptides corresponding to the hypervariable regions of the mismatched HLA-DR antigen(s) of the donor. Serial studies of 32 patients showed that T cell reactivity to donor allopeptides was strongly associated with episodes of acute rejection. The frequency of allopeptide reactive T cells was 10-50-fold higher in the graft than in the periphery indicating that T cells activated via the indirect allorecognition pathway participate actively in acute allograft rejection. In recipients carrying a graft differing by two HLA-DR alleles the response appeared to target only one of the mismatched antigens of the donor. Indirect allorecognition was restricted by a single HLA-DR antigen of the host and directed against one immunodominant peptide of donor HLA-DR protein. However, intermolecular spreading was demonstrated in patients with multiple rejection episodes by showing that they develop allopeptide reactivity against the second HLA-DR antigen. These data imply that early treatment to suppress T cell responses through the indirect pathway of allorecognition, such as tolerance induction to the dominant donor determinant, may be required to prevent amplification and perpetuation of the rejection process.

AB - To determine whether indirect allorecognition is involved in heart allograft rejection T cells obtained from peripheral blood and graft biopsy tissues were expanded in the presence of IL-2 and tested in limiting dilution analysis (LDA) for reactivity to synthetic peptides corresponding to the hypervariable regions of the mismatched HLA-DR antigen(s) of the donor. Serial studies of 32 patients showed that T cell reactivity to donor allopeptides was strongly associated with episodes of acute rejection. The frequency of allopeptide reactive T cells was 10-50-fold higher in the graft than in the periphery indicating that T cells activated via the indirect allorecognition pathway participate actively in acute allograft rejection. In recipients carrying a graft differing by two HLA-DR alleles the response appeared to target only one of the mismatched antigens of the donor. Indirect allorecognition was restricted by a single HLA-DR antigen of the host and directed against one immunodominant peptide of donor HLA-DR protein. However, intermolecular spreading was demonstrated in patients with multiple rejection episodes by showing that they develop allopeptide reactivity against the second HLA-DR antigen. These data imply that early treatment to suppress T cell responses through the indirect pathway of allorecognition, such as tolerance induction to the dominant donor determinant, may be required to prevent amplification and perpetuation of the rejection process.

KW - acute rejection

KW - allopeptide

KW - alloreactivity

KW - MHC- restriction

KW - T cell determinants

UR - http://www.scopus.com/inward/record.url?scp=9544241307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9544241307&partnerID=8YFLogxK

M3 - Article

C2 - 8787678

AN - SCOPUS:9544241307

VL - 98

SP - 1150

EP - 1157

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -